BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 2808278)

  • 1. Idiopathic thrombocytopaenic purpura in patients during remission of Hodgkin's disease.
    Tahiliani RR; Banavali SD; Parikh PM; Charak BS; Nair CN; Saikia TK; Gopal R; Advani SH
    J Assoc Physicians India; 1989 Feb; 37(2):141-3. PubMed ID: 2808278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic thrombocytopenic purpura in Hodgkin's disease--an early sign of a recurrence (author's transl)].
    Schmitt-Gräff A; Seeber S; Wetter O; Schmidt CG
    Dtsch Med Wochenschr; 1978 Nov; 103(46):1839-41. PubMed ID: 568541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic thrombocytopenic purpura and Hodgkin's disease: report of two cases and a review of the literature.
    Kirshner JJ; Zamkoff KW; Gottlieb AJ
    Am J Med Sci; 1980; 280(1):21-8. PubMed ID: 7191634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic thrombocytopenic purpura in Hodgkin's disease: a rare occurrence of no prognostic significance.
    Cohen JR
    Cancer; 1978 Feb; 41(2):743-6. PubMed ID: 564740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune thrombocytopenia in Hodgkin's disease].
    Burghuber OC; Smolen J; Kühböck J
    Acta Med Austriaca; 1986; 13(2):55-9. PubMed ID: 3766088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognostic significance of idiopathic thrombocytopenic purpura in patients with Hodgkin's disease in complete hematological remission.
    Martinelli G; Zinzani PL; Magagnoli M; Vianelli N; Tura S
    Haematologica; 1998 Jul; 83(7):669-70. PubMed ID: 9718878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of Hodgkin's disease and "idiopathic" thrombopenic purpura].
    Foa J; Duchamp C; Carcassonne Y
    Nouv Presse Med; 1978 Jan; 7(3):206. PubMed ID: 566434
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of Hodgkin's disease with thrombocytopenic purpura, polyneuritis, and cytomegalovirus pneumopathy (author's transl)].
    Duhamel G; Moise A; Najman A; Gorin N; Mayaud C; Chatelet F; Burguière AM
    Ann Med Interne (Paris); 1979; 130(10):449-53. PubMed ID: 231396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic thrombocytopenic purpura as the initial manifestation of Hodgkin's disease].
    Paz RA; Bolo H; Sanabria A
    Medicina (B Aires); 1980; 40(2):176-8. PubMed ID: 7191039
    [No Abstract]   [Full Text] [Related]  

  • 14. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune thrombocytopenic purpura in a child with Hodgkin's disease.
    Berberoğlu S; Sarialioğlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    Turk J Pediatr; 1995; 37(3):289-92. PubMed ID: 7502371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.